Progenics

exit

Progenics directors reportedly ousted in activist proxy fight

After a tooth-and-nail fight against the status quo at Progenics, private equity firm Velan reportedly has won a revamp of the drugmaker's board.

Kyle Blankenship Nov 11, 2019 10:30am

Emoji thumbs up

Proxy adviser backs ouster of Progenics CEO in activist battle

Oct 28, 2019 10:40am

With investors increasingly viewing hotels as a solid asset class strong corporate governance has never been more important

Activist investor calls for new board after Progenics merger try

Oct 10, 2019 10:10am

MIBG scans

Progenics buys a manufacturing facility for radiotherapeutic

Feb 12, 2019 10:24am

FDA

Progenics snags FDA nod for $300K Azedra

Jul 31, 2018 10:15am